Gene Therapy May Reverse Hemophilia

In a recent study, researchers altered the DNA of a common virus so that it would instruct the bodies of hemophiliacs to make the Factor IX (FIX) protein, which helps blood clot.

Companion Diagnostics: The Future of Personalized Medicine

Pairing genetic testing with treatment therapies helps physicians deliver better care to patients by identifying which therapies will be the most effective at specific doses.

Gene Therapy Tested for Hemophilia B

Amsterdam Molecular Therapeutics has begun a Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B.